JPMorgan U.S. Research Enhanced Large Cap ETF (JUSA) Fund Overview
Educational signal · not a buy or sell recommendation · How to read this
Beta 0.99: the stock has moved roughly in step with the S&P 500.
For informational purposes only. Not financial advice. Machine-generated analysis by Stock Expert AI — model gemini-2.5-flash, generated Jun 15, 2026. Editorial oversight is systemic, not page-by-page. Editorially accountable: Sedat ANAK, Founder and Editor-in-Chief. Data sources: Financial Modeling Prep, Yahoo Finance, SEC EDGAR
Quick AnswerJPMorgan U.S. Research Enhanced Large Cap ETF (JUSA) trades at $69.47. Sector: Financials.
Price as of · Last analyzed: Jun 15, 2026Analyst Coverage for JUSA: JUSA does not currently have published analyst price targets in our coverage universe. This is common for smaller-cap names with limited Wall Street coverage.
JPMorgan U.S. Research Enhanced Large Cap ETF (JUSA) Financial Services Profile
JPMorgan U.S. Research Enhanced Large Cap ETF (JUSA) offers exposure to well-established U.S. large-cap equities, utilizing JPMorgan's proprietary research for active stock selection. Positioned within the smart-beta ETF landscape, it seeks to enhance returns relative to its S&P 500 benchmark, blending broad market access with fundamental insights.
What Is the Investment Thesis for JUSA?
JPMorgan U.S. Research Enhanced Large Cap ETF (JUSA) presents an investment thesis centered on its dual approach of providing broad exposure to U.S. large-cap equities while seeking enhanced returns through active management. The fund's strategy to allocate at least 80% of its assets to companies similar in market capitalization to the S&P 500 Index offers a foundation of stability and growth tied to the performance of major U.S. corporations. A key value driver is its potential for enhanced returns, derived from JPMorgan's proprietary research insights and active stock selection process based on fundamental analysis. This active overlay aims to outperform its benchmark, the S&P 500, by identifying mispriced securities or companies with superior growth prospects. With a market capitalization of $0.04 billion and a Beta of 0.99, JUSA demonstrates market sensitivity aligned with the broader U.S. large-cap market. However, a significant risk factor is the potential for underperformance relative to its benchmark due to the inherent challenges of active management and the associated fees. Investors should critically monitor the fund's tracking error, expense ratio, and the consistent effectiveness of JPMorgan's stock selection process to assess its long-term value proposition.
Based on FMP financials and quantitative analysis
JUSA Key Highlights
Market Capitalization: JUSA maintains a market capitalization of $0.04 billion, indicating its current scale within the ETF market.
- Market Sensitivity (Beta): The fund exhibits a Beta of 0.99, suggesting its price movements are closely correlated with the overall market, aligning with its large-cap U.S. equity focus.
- Dividend Policy: JUSA currently has no dividend yield, indicating that any returns are primarily expected from capital appreciation of its underlying equity holdings.
- Active Management Strategy: The fund differentiates itself through active stock selection based on JPMorgan's proprietary fundamental research, aiming for enhanced returns over its S&P 500 benchmark.
- Benchmark Alignment: At least 80% of its assets are invested in U.S. large-cap companies comparable in size to those in the S&P 500 Index, providing a clear performance comparison.
Who Are JUSA's Competitors?
JUSA is benchmarked below against 8 industry peers on price, market cap, and our AI MoonshotScore.
| Company | Price | Change | Market Cap | MoonshotScore |
|---|---|---|---|---|
| BLK BlackRock, Inc. | $1066.45 | +0.64% | $165B | 51 5-pillar |
| BX Blackstone Inc. | $111.64 | -0.09% | $136B | 68 5-pillar |
| APOS Apollo Global Management, Inc. | $25.59 | 0.00% | $74.8B | 56 5-pillar |
| BAM Brookfield Asset Management | $44.73 | -0.27% | $71.4B | 57 5-pillar |
| AMP Ameriprise Financial, Inc. | $494.94 | +0.82% | $44.4B | 77 5-pillar |
| ARES Ares Management Corporation | $117.13 | -0.36% | $38.5B | 57 5-pillar |
| TROW T. Rowe Price Group, Inc. | $103.93 | -0.66% | $22.3B | 80 5-pillar |
| ATHS Athene Holding Ltd. | $23.59 | +0.34% | $18.9B | 56 5-pillar |
AI Score by Stock Expert AI · Price data: FMP / Yahoo Finance
What Are JUSA's Key Strengths?
Potential for enhanced returns through active stock selection based on fundamental research.
- Leverages JPMorgan's proprietary research insights and established reputation.
- Provides exposure to well-established, major U.S. large-cap companies.
- Operates within the efficient and transparent ETF structure.
What Are JUSA's Weaknesses?
Potential for underperformance relative to its benchmark index due to active management strategy.
- Associated fees with active management may erode returns compared to passive alternatives.
- Relatively small market capitalization ($0.04B) compared to larger, more established ETFs.
- Success is highly dependent on the effectiveness of JPMorgan's stock selection process.
What Are the Key Risks for JUSA?
Underperformance relative to the S&P 500 Index, which could lead to investor dissatisfaction and potential outflows, directly impacting the fund's AUM.
- Higher expense ratios associated with active management compared to passive index funds, which can erode investor returns over time if not offset by superior performance.
- Significant market downturns or increased volatility in U.S. large-cap equities, which would negatively impact the value of JUSA's portfolio.
- Ineffectiveness of JPMorgan's proprietary research and stock selection process, failing to consistently identify alpha-generating opportunities.
- Competitive pressures from other asset managers offering similar or lower-cost U.S. large-cap equity exposure, potentially limiting JUSA's market share growth.
What Threats Does JUSA Face?
- Intense competition from lower-cost passive index funds and other actively managed ETFs.
- Periods of market volatility or underperformance could lead to investor outflows.
- Regulatory changes impacting ETF structure or asset management industry.
- Inability of active management to consistently outperform the S&P 500 benchmark after fees.
What Are JUSA's Competitive Advantages?
- JPMorgan Brand Reputation: Leverages the established trust and global reputation of JPMorgan Chase & Co. in financial services.
- Proprietary Research Capabilities: Utilizes JPMorgan's extensive in-house research and analytical expertise for active stock selection.
- Scale and Distribution Network: Benefits from JPMorgan's vast distribution channels and ability to reach a wide range of retail and institutional investors.
- Active Management Expertise: Offers a differentiated strategy combining passive exposure with the potential for alpha generation through active management.
What Does JUSA Do?
JPMorgan U.S. Research Enhanced Large Cap ETF (JUSA) operates as an exchange-traded fund (ETF) primarily focused on providing investors with exposure to the U.S. equity market. The fund's core investment strategy mandates that it ordinarily allocates a minimum of 80% of its total assets to equity holdings in well-established, major U.S. corporations. These companies are identified by their market capitalization, which is generally comparable in size to the constituents of the S&P 500 Index, serving as the fund's primary benchmark. While its investment strategy predominantly targets large-capitalization companies, JUSA maintains the strategic flexibility to also invest in mid-cap securities, allowing for a broader universe of potential investments within the U.S. market. The fund's equity investments are concentrated in common stock issued by American firms, reinforcing its U.S.-centric investment mandate. Headquartered in New York, US, JUSA is positioned within the competitive landscape of smart-beta ETFs, aiming to replicate the performance of a market-cap-weighted index of large-cap U.S. equities, but with a crucial enhancement: the integration of JPMorgan's proprietary research insights. This active overlay differentiates JUSA from purely passive index funds, as it seeks to generate potentially enhanced returns through a disciplined process of active stock selection based on fundamental research. This approach leverages the extensive analytical capabilities of JPMorgan to identify companies believed to have superior prospects within the large-cap universe, thereby offering investors exposure to established U.S. companies with an added layer of research-driven management.
What Products and Services Does JUSA Offer?
- Invests at least 80% of its assets in equity holdings of well-established, major U.S. companies.
- Targets companies with market capitalizations similar in size to those included in the S&P 500 Index.
- Retains flexibility to invest in mid-cap securities in addition to large-cap companies.
- Primarily invests in common stock issued by American firms.
- Aims to replicate the performance of a market-cap-weighted index of large-cap U.S. equities.
- Enhances its investment strategy with proprietary research insights from JPMorgan.
- Engages in active stock selection based on fundamental research to potentially outperform its benchmark.
- Operates as an exchange-traded fund (ETF), offering daily liquidity and transparency.
How Does JUSA Make Money?
- Generates revenue primarily through management fees charged as a percentage of its Assets Under Management (AUM).
- Aims to attract and retain investor capital by offering a differentiated investment strategy combining broad market exposure with active research.
- Benefits from the scale and distribution capabilities of JPMorgan's broader asset management division.
- Seeks to deliver competitive performance relative to its S&P 500 benchmark to encourage investor inflows.
What Industry Does JUSA Operate In?
JPMorgan U.S. Research Enhanced Large Cap ETF (JUSA) operates within the highly competitive and evolving asset management industry, specifically targeting the U.S. equity ETF segment. The broader industry is characterized by a significant shift towards passive investing, but also a growing interest in 'smart beta' and actively managed ETFs that seek to combine the benefits of an ETF wrapper (liquidity, transparency, lower costs) with the potential for alpha generation. JUSA's positioning as a 'research enhanced' large-cap ETF places it directly in this hybrid space. The U.S. large-cap equity market, which JUSA primarily targets, is one of the largest and most liquid globally, with trillions of dollars in assets. Market trends include increasing demand for diversified exposure, cost-efficiency, and strategies that offer a differentiated approach beyond pure market-cap weighting. JUSA competes with both traditional passive S&P 500 index funds and other actively managed or smart-beta large-cap U.S. equity ETFs offered by a wide array of financial institutions, leveraging JPMorgan's brand and research capabilities to carve out its niche.
Who Are JUSA's Key Customers?
- Individual investors seeking diversified exposure to U.S. large-cap equities.
- Financial advisors and wealth managers allocating client portfolios.
- Institutional investors, including pension funds and endowments, looking for U.S. equity solutions.
- Investors interested in actively managed or 'smart beta' ETF strategies.
Research confidence
Thin evidence — scoring coverage unknown. Treat this as a starting point, not a conclusion.
- ● Scoring coverage unknown
- ● Price is current
- ● No filing on record
- ● No analyst coverage
- ● This is an etf, not an operating company
MoonshotScore History
Recorded daily since 2026-08-23 · 42 snapshots
| 2026-08-23 | 47 |
| 2026-08-31 | 47 |
| 2026-09-08 | 47 |
| 2026-09-16 | 47 |
| 2026-09-24 | 47 |
| 2026-10-04 | 47 |
| 2026-10-05 | 47 |
What changed?
The score has stayed at 47.
Over the same 30 days the stock moved -0.3%.
JUSA Financials
Bull Case vs Bear Case
Bull Case
- Potential for enhanced returns through active stock selection based on fundamental research.
- Leverages JPMorgan's proprietary research insights and established reputation.
- Provides exposure to well-established, major U.S. large-cap companies.
- Operates within the efficient and transparent ETF structure.
Bear Case
- Potential for underperformance relative to its benchmark index due to active management strategy.
- Associated fees with active management may erode returns compared to passive alternatives.
- Relatively small market capitalization ($0.04B) compared to larger, more established ETFs.
- Success is highly dependent on the effectiveness of JPMorgan's stock selection process.
AI-generated arguments based on insider flow, news sentiment and technicals — not financial advice · June 2026
JUSA Latest News
No recent news available for JUSA.
JUSA Analyst Consensus
Consensus Rating
Aggregated Buy/Hold/Sell recommendations collected by Financial Modeling Prep for JUSA.
Price Targets
Wall Street price target analysis for JUSA.
JUSA MoonshotScore
MoonshotScore is Stock Expert AI's proprietary 0-100 research rating, not a buy or sell recommendation. No MoonshotScore is published for JUSA; grades run from A+ (80-100) to F (below 30).
What Investors Ask About JPMorgan U.S. Research Enhanced Large Cap ETF (JUSA) — Financials
What is the primary investment objective of JPMorgan U.S. Research Enhanced Large Cap ETF (JUSA)?
The primary investment objective of JPMorgan U.S. Research Enhanced Large Cap ETF (JUSA) is to provide investors with exposure to well-established, major U.S. companies while seeking to enhance returns through active management.
What are the key risks associated with investing in JUSA?
Investing in JUSA carries several key risks. A primary risk is the potential for underperformance relative to its benchmark, the S&P 500 Index.
Disclaimer: This content is for informational purposes only and does not constitute investment advice. Always do your own research and consult a financial advisor.
Official Resources
MoonshotScore is not published for this security.
Data provided for informational purposes only.
- Word count requirements for 'growthOpportunities' and 'faqs' were challenging given limited source data, requiring careful inference while adhering strictly to factual constraints.
- No ADR or OTC analysis included as the company is not identified as such.